DESIGN AND DEVELOPMENT OF NANOEMULSION OF SMILAX CHINA FOR ANTI-PSORIASIS ACTIVITY
DOI:
https://doi.org/10.22159/ijpps.2024v16i5.50327Keywords:
Smilax china, Tween80, High-speed homogenization method, Antipsoriatic, NanoemulsionAbstract
Objective: The present investigation aimed to prepare a smilax china loaded nanoemulsion using tween 80 as a surfactant and propylene glycol as a co-surfactant. Formulation of such drugs in nanoparticulate drug delivery will be advantageous for reducing dosing frequency, longer residence time, improved permeation, and patient compliance.
Methods: High-speed homogenization method. The smilax china oil was prepared by collecting the extract of smilax china leaves into the coconut oil and then used as a solvent. The authentication studies of smilax china and coconut oil were evaluated for their organoleptic and physicochemical characteristics. The quantitative estimation and pre-formulation study of quercetin was carried out which has major anti-psoriatic properties. Surfactant and co-surfactant were selected and the solubility studies of oil and Surfactants were done. The nanoemulsion was characterized by particle size, polydispersity index, zeta potential, and entrapment efficiency (%).
Results: This nanoemulsion provides the particle size and entrapment efficiency range between 80.52 to 89.78 nm and 68.66 to 70.16 % respectively. Batch SC1 showed the lowest particle size, PDI, and optimized drug entrapment effectiveness (%), indicating good particle size consistency within the remaining formulation batches. The optimized formulation SC 1 was found to be stable for 90 d.
Conclusion: The formulated nanoemulsion showed significant antipsoriasis activity due to the presence of quercetin which has a rhetorical yield of 1.066 mg per 5 gm powder of smilax china leaves. Formulated smilax china-loaded nanoemulsion, has the potential as an effective antipsoriasis agent with a good spreading property with faster absorption which is beneficial for reducing drug concentration with maximum therapeutic effect.
Downloads
References
Di Meglio P, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med. 2014 Aug 1;4(8):a015354:a015354. doi: 10.1101/cshperspect.a015354, PMID 25085957, PMCID PMC4109580.
Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3, May):170-3. doi: 10.7861/clinmed.2021-0257, PMID 34001566.
Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64Suppl 2:ii18-24. doi: 10.1136/ard.2004.033217, PMID 15708928.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18, Sep):4347. doi: 10.3390/ijms20184347, PMID 31491865.
Karmacharya P, Chakradhar R, Ogdie A. The epidemiology of psoriatic arthritis: a literature review. Best Pract Res Clin Rheumatol. 2021;35:101692. doi: 10.1016/j.berh.2021.101692, PMID 34016528.
Antony A, Tillett W. Diagnosis, classification, and assessment in psoriatic arthritis. Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101669. doi: 10.1016/j.berh.2021.101669, PMID 33839045.
Bhutani T, Liao W, Nakamura M, editors. Evidence-based psoriasis. Updates in clinical dermatology. Berlin: Springer International Publishing; 2018. doi: 10.1007/978-3-319-90107-7.
Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND. Update on psoriasis: a review. J Family Med Prim Care. 2020;9(1):20-4. doi: 10.4103/jfmpc.jfmpc_689_19. PMID 32110559.
Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M. Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci. 2021 May 7;22(9):22(9):4983. doi: 10.3390/ijms22094983, PMID 34067151.
Man AM, Orasan MS, Hoteiuc OA, Olanescu Vaida-Voevod MC, Mocan T. Inflammation and psoriasis: a comprehensive review. Int J Mol Sci. 2023 Nov 8;24(22):16095. doi: 10.3390/ijms242216095, PMID 38003284.
Lee HJ, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023 Aug 28;24(17):13313. doi: 10.3390/ijms241713313, PMID 37686119, PMCID PMC10487560.
Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020 May 19;323(19):1945-60. doi: 10.1001/jama.2020.4006, PMID 32427307.
Vincent N, Ramya DD, Vedha HB. Progress in psoriasis therapy via novel drug delivery systems. Dermatol Reports. 2014 Sep 8;6(1):5451. doi: 10.4081/dr.2014.5451, PMID 25386329, PMCID PMC4224007.
Ufimtseva MA, Popov AA, Fedotova LV, Mylnikova ES, Bochkarev YuM, Zhunisova DS. Psoriasis and metabolic syndrome: a review. Obes Metabol. 2020 Dec 25;17(4):369-74. doi: 10.14341/omet12517.
Iriventi P, Guota N. Nanotechnology in management of psoriasis: a focus on herbal therapy. Indo Am J Pharm Res. 2017;7(1):7417-27. doi: 10.5281/zenodo.1006782.
Jufrı M, Iswandana R, Wardani DA, Malık SF. Formulatıon of red fruit oil nanoemulsion using sucrose palmitate. Int J App Pharm. 2022 Sep 7:175-80. doi: 10.22159/ijap.2022v14i5.44314.
Mohamad HS, Wenli S, Qi C. Tremendous health benefits and clinical aspects of Smilax china. Afr J Pharm. 2019 Oct 31;13(16):253-8. doi: 10.5897/AJPP2019.5070.
Tripathi D, Srivastava M, Rathour K, Rai AK, Wal P, Sahoo J. A promising approach of dermal targeting of antipsoriatic drugs via engineered nanocarriers drug delivery systems for tackling psoriasis. Drug Metab Bioanal Lett. 2023;16(2):89-104. doi: 10.2174/2949681016666230803150329, PMID 37534794.
Khan I, Nisar M, Ebad F, Nadeem S, Saeed M, Khan H. Anti-inflammatory activities of sieboldogenin from smilax china linn.: experimental and computational studies. J Ethnopharmacol. 2009;121(1):175-7. doi: 10.1016/j.jep.2008.10.009. PMID 19007873.
Peng J, Dong WJ, Li L, Xu JM, Jin DJ, Xia XJ. Effect of high-pressure homogenization preparation on mean globule size and large-diameter tail of oil-in-water injectable emulsions. J Food Drug Anal. 2015;23(4):828-35. doi: 10.1016/j.jfda.2015.04.004, PMID 28911501.
Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017 Apr;63(4):278-85. PMID 28404701, PMCID PMC5389757.
Marzano AV, Derlino F, Berti EF. Pathogenesis of psoriasis: focus on autoinflammation. Dermatopathology (Basel). 2018 Feb 2;5(1):14-5. doi: 10.1159/000486304, PMID 29719825, PMCID PMC5920958.
Boulton DW, Walle UK, Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol. 1998 Feb;50(2):243-9. doi: 10.1111/j.2042-7158.1998.tb06183.x, PMID 9530994.
Labouta HI, el-Khordagui LK, Kraus T, Schneider M. Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale. 2011 Dec;3(12):4989-99. doi: 10.1039/c1nr11109d, PMID 22064944.
Jakka V, Gayatrıramyamunagala DSP Patnala, R Kuruba. Nanosuspensıons: a strategy to increase the solubility and bioavailability of poorly water-soluble drugs. Asian J Pharm Clin Res. 2023;16(5):33-40. doi: 10.22159/ajpcr.2023.v16i5.46617.
Sumathi R, Tamizharasi S, Sivakumar T. Formulatıon and evaluation of polymeric nanosuspension of naringenin. Int J App Pharm. 2017;9:60. doi: 10.22159/ijap.2017v9i6.21674.
Hirlekar SDS, Bhairy S, Bhairy S, Hirlekar R, Hirlekar R. Preparatıon and characterization of oral nanosuspension loaded with curcumin. Int J Pharm Pharm Sci. 2018;10:90. doi: 10.22159/ijpps.2018v10i6.22027.
Kilor V, Sapkal N, Daud A, Humne S, Gupta T. Development of stable nanosuspension loaded oral films of glimepiride with improved bioavailability. Int J App Pharm. 2017;9(2, Mar):28. doi: 10.22159/ijap.2017v9i2.16714.
Purkayastha HD, Hossian SKI. Nanosuspensıon: a modern technology used in drug delıvery system. Int J Curr Pharm Sci. 2019 May:1-3. doi: 10.22159/ijcpr.2019v11i3.34098.
Singh D, Shrivastava S, Murthy C, Singh M, Pradhan M. Skin autoimmune disorders: lipid biopolymers and colloidal delivery systems for topical delivery. Sci Pharm. 2016;11(1):257-96. doi: 10.1016/B978-0-323-42868-2.00011-5.
Velraj M, Vijayalaxmi A, Ravichandiran V, Jayakumari S, Malarkodi V, Nirmala S. Screening of flavonoid ”quercetin” from the rhizome of smilax china linn. for antipsoriatic activity. Asian Pac J Biomed. 2012;5:269-75. doi: 10.1016/s2221-1691(12)60021-5.
Wang M, Bai QX, Zheng XX, Hu WJ, Wang S, Tang HP. Smilax china L.: a review of its botany, ethnopharmacology, phytochemistry, pharmacological activities, actual and potential applications. J Ethnopharmacol. 2024 Jan 10;318(B):116992. doi: 10.1016/j.jep.2023.116992, PMID 37541403.
Gardouh AR, Faheim SH, Noah AT, Ghorab MM. Influence of formulation factors on the size of nanostructured lipid carriers and nanoemulsions prepared by high shear homogenization. Int J Pharm Pharm Sci. 2018 Apr 1;10(4):10(4):61. doi: 10.22159/ijpps.2018v10i4.23142.
Ledet G, Pamujula S, Walker V, Simon S, Graves R, Mandal TK. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm. 2014;40(3):370-9. doi: 10.3109/03639045.2012.763137. PMID 23600657.
Srivastava R. A review on phytochemical, pharmacological, and pharmacognostical profile of wrightia tinctoria: adulterant of kurchi. Pharmacogn Rev. 2014;8(15):36-44. doi: 10.4103/0973-7847.125528, PMID 24600194.
Ghosh V, Saranya S, Mukherjee A, Chandrasekaran N. Cinnamon oil nanoemulsion formulation by ultrasonic emulsification: investigation of its bactericidal activity. J Nanosci Nanotechnol. 2013;13(1):114-22. doi: 10.1166/jnn.2013.6701, PMID 23646705.
Habibvand M, Yousefi M, Ahmed SA, Hassanzadeh H. Formulation of nanoemulsion carriers containing pennyroyal (Mentha pulegium) and Gijavash (Froriepia subpinnata) essential oils for enriching doogh (Iranian dairy drink). IET Nanobiotechnol. 2023 Apr;17(2):80-90. doi: 10.1049/nbt2.12106. PMID 36478175, PMCID PMC10116015.
Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3, Dec):1126-41. doi: 10.1016/j.jconrel.2013.08.006, PMID 23954372.
Goel S, Sachdeva M, Agarwal V. Nanosuspension technology: recent patents on drug delivery and their characterizations. Recent Pat Drug Deliv Formul. 2019;13(2):91-104. doi: 10.2174/1872211313666190614151615, PMID 31203813.
Arora D, Khurana B, Rath G, Nanda S, Goyal AK. Recent advances in nanosuspension technology for drug delivery. Curr Pharm Des. 2018;24(21):2403-15. doi: 10.2174/1381612824666180522100251, PMID 29788880.
Casula L, Pireddu R, Cardia MC, Pini E, Valenti D, Schlich M. Nanosuspension-based dissolvable microneedle arrays to enhance diclofenac skin delivery. Pharmaceutics. 2023 Sep 9;15:2308. doi: 10.3390/pharmaceutics15092308, PMID 37765277.
Pınar SG, Oktay AN, Karakucuk AE, Celebi N. Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics. 2023 May 5;15:1520. doi: 10.3390/pharmaceutics15051520, PMID 37242763.
Patel VR, Agrawal YK. Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res. 2011 Apr 02;2:81-7. doi: 10.4103/2231-4040.82950, PMID 22171298.
Chin WW, Parmentier J, Widzinski M, Tan EH, Gokhale R. A brief literature and patent review of nanosuspensions to a final drug product. J Pharm Sci. 2014;103:2980-99. doi: 10.1002/jps.24098, PMID 25099918.
Bhat M, Pukale SS, Singh S, Mittal A, Chitkara D. Nano-enabled topical delivery of anti-psoriatic small molecules. Journal of Drug Delivery Science and Technology. 2021 Apr 1;62. doi: 10.1016/j.jddst.2021.102328.
Wu H, Wang Y, Zhang B, Li YL, Ren ZX, Huang JJ. Smilax glabra Roxb.: a review of its traditional usages, phytochemical constituents, pharmacological properties, and clinical applications. Drug Des Devel Ther. 2022;16:3621-43. doi: 10.2147/DDDT.S374439, PMID 36277602.
Zuccari G, Alfei S. Development of phytochemical delivery systems by nano-suspension and nano-emulsion techniques. Int J Mol Sci. 2023;24:9824. doi: 10.3390/ijms24129824, PMID 37372971.
Azimullah S, Vikrant, Sudhakar C, Kumar P, Patil A, Usman MR. Nanosuspensions as a promising approach to enhance bioavailability of poorly soluble drugs: an update. J Drug Delivery Ther. 2019;9(2):574-82. doi: 10.22270/jddt.v9i2.2436.
Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24:3. doi: 10.1186/s40824-020-0184-8, PMID 31969986.
Karthick G, Akiladevi D, Ahamed MI. A comprehensive review of a new nanosuspension for improving the oral bioavailability of poorly soluble drugs. J Pharm Res Int. 2022;24:16-21. doi: 10.9734/jpri/2022/v34i20B35828.
Budhrani AB, Sahu KG, Lote SB, Deshmukh MP, Wankhede SB, Khobragade DS. Nanosuspension: a modern approach in drug delivery system-a review. Int J Res Pharm Sci. 2020 Dec;11(SPL4):1526-30. doi: 10.26452/ijrps.v11iSPL4.4333.
Hirlekar SDS, Bhairy S, Bhairy S, Hirlekar R, Hirlekar R. Preparation and characterization of oral nanosuspension loaded with curcumin. Int J Pharm Pharm Sci;10(6):90-6. doi: 10.22159/ijpps.2018v10i6.22027.
Poulose P, Shreej K. Formulation and in vitro evaluation of mebendazole nanoemulsion containing oregano essential oil. Int J Curr Res 2017;9(6):52601-10.
Jain R, Rajput S. Development of pharmacognostical parameters and estimation of quercetin using HPTLC in leaves of nelumbo nucifera gaertn. Pharmacogn J. 2012;4(34):31-7. doi: 10.5530/pj.2012.34.6.
Akinola AA, Ahmad S, Maziah M. Total antioxidant capacity, total phenolic compounds and the effects of solvent concentration on flavonoid content in curcuma longa and curcuma xanthorhhiza rhizomes. Med Aromat Plants 2014;3:2. doi: 10.4172/2167-0412.1000156.
Patel R, Joshi J. An overview on nanoemulsion: a novel approach. Int J Pharm Sci Res. 2012;3(12):4640-50. doi: 10.13040/IJPSR0975-82323(12)4640-50.
Alam MS, Ali MS, Alam N, Siddiqui MR, Shamim M, Safhi MM. In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis. Drug Invent Today. 2013;5(1):8-12. doi: 10.1016/j.dit.2013.02.001.
Ngan CL, Basri M, Lye FF, Fard Masoumi HR, Tripathy M, Karjiban RA. Comparison of process parameter optimization using different designs in nanoemulsion-based formulation for transdermal delivery of fullerene. Int J Nanomedicine. 2014 Sep 15;9:4375-86. doi: 10.2147/IJN.S65689, PMID 25258528, PMCID PMC4172124.
Anand S, Kumar KR. Design, development and optimisation of carvedilol microemulsion by pseudoternary phase diagram and central composite design. Int J Res Pharm Sci. 2020;11(4):6619-32. doi: 10.26452/ijrps.v11i4.3569.
Shaker DS, Ishak RAH, Ghoneim A, Elhuoni MA. Nanoemulsion: a review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci Pharm. 2019;87(3):2-34. doi: 10.3390/scipharm87030017.
K Gurpret, SK Singh. Review of nanoemulsion formulation and characterization techniques. Indian J Pharm Sci. 2018;80(5). doi: 10.4172/pharmaceutical-sciences.1000422.
Kulawik Pioro A, Miastkowska M. Polymeric gels and their application in the treatment of psoriasis vulgaris: a review. Int J Mol Sci. 2021;22(10):5124. doi: 10.3390/ijms22105124, PMID 34066105.
Laila L, Candra A, Permata YM, Prasetyo BE. The influence of catharanthus roseus (l.) g. don. ethanol extract in clove oil nanoemulsion: physical characterization, antioxidant and antibacterial activities. Int J App Pharm. 2023;15(3):254-60. doi: 10.22159/ijap.2023v15i3.47138.
Sunil Dhoot A, Naha A, JuhiPriya JJ, NehaXalxo NN. Phase diagrams for three component mixtures in pharmaceuticals and its applications. JYP. 2018;10(2):132-7. doi: 10.5530/jyp.2018.10.31.
Jyothi SL, Krishna KL, Ameena Shirin VK, Sankar R, Pramod K, Gangadharappa HV. Drug delivery systems for the treatment of psoriasis: current status and prospects. J Drug Deliv Sci Technol. 2021;62(Apr):102364. doi: 10.1016/j.jddst.2021.102364.
Gomes GS, Frank LA, Contri RV, Longhi MS, Pohlmann AR, Guterres SS. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis. Int J Pharm. 2023;631(Jan):122535. doi: 10.1016/j.ijpharm.2022.122535, PMID 36566826.
Parmar PK, Sharma N, Wasil Kabeer S, Rohit A, Bansal AK. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses. Int J Pharm. 2022;622:121873. doi: 10.1016/j.ijpharm.2022.121873, PMID 35640806.
Ramanunny AK, Wadhwa S, Kumar Singh S, Kumar B, Gulati M, Kumar A. Topical non-aqueous nanoemulsion of Alpinia Galanga extract for effective treatment in psoriasis: in vitro and in vivo evaluation. Int J Pharm. 2022;624:121882. doi: 10.1016/j.ijpharm.2022.121882, PMID 35671853.
Laurindo LF, de Carvalho GM, de Oliveira Zanuso B, Figueira ME, Direito R, de Alvares Goulart R. Curcumin-based nanomedicines in the treatment of inflammatory and immunomodulated diseases: an evidence-based comprehensive review. Pharmaceutics. 2023;15:229. doi: 10.3390/pharmaceutics15010229, PMID 36678859.
Casula L, Pireddu R, Cardia MC, Pini E, Valenti D, Schlich M. Nanosuspension-based dissolvable microneedle arrays to enhance diclofenac skin delivery. Pharmaceutics. 2023 Sep 13;15(9):2308. doi: 10.3390/pharmaceutics15092308, PMID 37765277, PMCID PMC10536216.
Wang M, Bai QX, Zheng XX, Hu WJ, Wang S, Tang HP. Smilax china L.: a review of its botany, ethnopharmacology, phytochemistry, pharmacological activities, actual and potential applications. J Ethnopharmacol. 2024 Jan 10;318(B):116992. doi: 10.1016/j.jep.2023.116992, PMID 37541403.
Joo JH, Han MH, Kim JI, Kim JE, Jung KH, Oh HS. Antimicrobial activity of Smilax china L. root extracts against the acne-causing bacterium, cutibacterium acnes, and its active compounds. Molecules. 2022 Nov 29;27(23):8331. doi: 10.3390/molecules27238331, PMID 36500424, PMCID PMC9736125.
Published
How to Cite
Issue
Section
Copyright (c) 2024 VISHAL BODKE, PRADNYA KUMBHAR, SHREEYA BELWALKAR, AKASH S. MALI, KARISHMA WAGHMARE
This work is licensed under a Creative Commons Attribution 4.0 International License.